Author(s):
Manisha Kalariya, Chetan Borkhataria, Rachana Katbamna, Rakesh Prajapati
Email(s):
mkalaria67@gmail.com
DOI:
10.52711/0974-360X.2026.00147 
Address:
Manisha Kalariya1, Chetan Borkhataria2, Rachana Katbamna3, Rakesh Prajapati4
1,2,3B.K. Mody Govt. Pharmacy College, Rajkot, Gujarat, 360003, India.
4Vidhyadeep Institute of Pharmacy, Surat, Gujarat, 395017, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 3,
Year - 2026
ABSTRACT:
Throughout the past few decades, the suppression of spontaneous marble burying behavior in mice, using glass marbles, has been utilized as measure of antianxiety drug efficacy in the marble-burying behavior test. Citrus medica reported for the treatment of various diseases and ailments in humans and animals in different systems of traditional medicine. Despite the numerous medicinal properties of Citrus medica (Rutaceae), known as citron, its neurological effects remain largely unexplored. This is the first study to assess the anti-obsessive-compulsive disorder (anti-compulsive) effects of the methanolic extract of Citrus medica fruits (MECM) using the marble-burying behavior test in mice. This study was carried out using Swiss albino mice as an animal model to assess marble-burying behavior. MECM (25, 50, 100mg/kg, i.p.) reduced marble-burying behavior of mice in a dose-dependent manner, similar to the effect of fluoxetine (5mg/kg, i.p.), a drug commonly used to treat obsessive-compulsive disorder. Neither fluoxetine nor MECM caused any overt motor disfunction. Preliminary phytochemical investigation of MECM shows that flavonoid glycosides, limonene, linalool, steroids and ß-sitosterol are present in MECM. This study provides the first evidence that the fruit exhibits anti-compulsive activity, corroborating traditional claims. Future studies should aim to isolate and characterize the bioactive compounds in this fruit and assess their potential to mitigate compulsive behaviors through preclinical and clinical evaluations.
Cite this article:
Manisha Kalariya, Chetan Borkhataria, Rachana Katbamna, Rakesh Prajapati. Evaluation of Anti-Compulsive effects of Methanolic extract of Citrus medica Fruits in Mice. Research Journal Pharmacy and Technology. 2026;19(3)1042-6: doi: 10.52711/0974-360X.2026.00147
Cite(Electronic):
Manisha Kalariya, Chetan Borkhataria, Rachana Katbamna, Rakesh Prajapati. Evaluation of Anti-Compulsive effects of Methanolic extract of Citrus medica Fruits in Mice. Research Journal Pharmacy and Technology. 2026;19(3)1042-6: doi: 10.52711/0974-360X.2026.00147 Available on: https://rjptonline.org/AbstractView.aspx?PID=2026-19-3-8
REFERENCES:
1. Murphy DL, Timpano KR, Wheaton MG, Greenberg BD, Miguel EC. Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci. 2010; 12(2): 131-48.
2. Voderholzer U, Favreau M, Rubart A, Staniloiu A, Wahl-Kordon A, Zurowski B, et al. Therapie der Zwangsstörungen: Empfehlungen der revidierten S3-Leitlinie Zwangsstörungen. Nervenarzt. 2022; 93(7): 678-87.
3. Tavakolizadeh J, Safarzade S. The prevalence of obsessive-compulsive disorder in the population of 18–66-year-old city of Gonabad-Iran in 2016. Res J Pharm Technol. 2018; 11(10): 4222.
4. M S, Prabakar S, Rao UM. Cognitive behavioral therapy in children and adolescents. Res J Pharm Technol. 2022; 15(3): 1330-6.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Washington DC: APA; 2023. doi:10.1176/appi.books.9780890425787.
6. International Advisory Group for the Revision of ICD-10 Mental and Behavioral Disorders. A conceptual framework for the revision of the ICD-10 classification of mental and behavioral disorders. World Psychiatry. 2011; 10(2): 86-92.
7. Abramowitz JS, Reuman L. Obsessive compulsive disorder. In: Zeigler-Hill V, Shackelford TK, editors. Encyclopedia of Personality and Individual Differences. Cham: Springer; 2020. p. 3304-6.
8. Heyman I, Mataix-Cols D, Fineberg NA. Obsessive-compulsive disorder. BMJ. 2006; 333(7565): 424-9.
9. Abramowitz JS, Taylor S, McKay D. Obsessive-compulsive disorder. Lancet. 2009; 374(9688): 491-9.
10. Fontenelle LF, Hasler G. Understanding the course of obsessive–compulsive disorder: a meta-analysis and qualitative review. J Obsessive Compuls Relat Disord. 2020; 27: 100587.
11. Njung’e K, Handley SL. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav. 1991; 38(1): 63-7.
12. Aboul-Fotouh S, Eid A, El-Khayat Z. Marble-burying behavior in rodents: uncovering the neurobiology, relevance, and reliability. J Pers Med. 2022; 12(11): 1921. doi:10.3390/jpm12111921.
13. de Boer SF, Koolhaas JM. Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol. 2003; 463(1-3): 145-61. doi:10.1016/S0014-2999(03)01278-0.
14. Wilkie DM, MacLennan AJ, Pinel JPJ. Rat defensive behavior: burying noxious food. J Exp Anal Behav. 1979; 31(3): 299-306.
15. Deacon RMJ. Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc. 2006; 1(1): 122-4.
16. De Brouwer G, Fick A, Harvey BH, Wolmarans W. A critical inquiry into marble burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: mapping the way forward. Cogn Affect Behav Neurosci. 2019; 19(1): 1-39. doi:10.3758/s13415-018-00653-4.
17. Benedetto N, Carlucci V, Faraone I, Lela L, Ponticelli M, Russo D, et al. An insight into Citrus medica Linn.: a systematic review on phytochemical profile and biological activities. Plants (Basel). 2023; 12(12): 2267.
18. Malleshappa P, Kumaran RC, Venkatarangaiah K, Parveen S. Peels of Citrus fruits: a potential source of anti-inflammatory and anti-nociceptive agents. Pharmacogn J. 2018; 10(6s): 172-8.
19. Sah AN, Joshi A, Juyal V, Kumar T. Antidiabetic and hypolipidemic activity of Citrus medica Linn. seed extract in streptozotocin induced diabetic rats. Pharmacogn J. 2011; 3(23): 80-4.
20. Nagaraju B, Anand S, Ahmed N, Narendra J, Chandra S, Ahmed F, et al. Antiulcer activity of aqueous extract of Citrus medica Linn. fruit against ethanol-induced ulcer in rats. Adv Biol Res. 2012; 6: 24-9.
21. Al-Yahya M, Mothana R, Al-Said M, El-Tahir K, Al-Sohaibani M, Rafatullah S. Citrus medica “Otroj”: attenuates oxidative stress and cardiac dysrhythmia in isoproterenol-induced cardiomyopathy in rats. Nutrients. 2013; 5(11): 4269-83.
22. Kirtikara KR, Basu BD. Indian medicinal plants. Kolkata: Panini Office; 1918. Available from: http://dx.doi.org/10.5962/bhl.title.137025.
23. Bembde NS, Meshram PV, Patil MK, Shaikh J. The preliminary phytochemical analysis of ethanolic extract of Tylophora indica. Res J Pharmacogn Phytochem. 2020; 12(1): 1.
24. Yogita S, Kumar JA. Effects of maternal fluoxetine treatment on anxiety parameters in the rat progeny. Res J Pharmacol Pharmacodyn. 2017; 9(3): 137.
25. OECD. Revised introduction to the OECD guidelines for testing of chemicals, section 3. Paris: OECD Publishing; 2006. doi:10.1787/9789264030213-en.
26. Njung’e K, Handley SL. Effects of 5‐HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice: a putative test for anxiolytic agents. Br J Pharmacol. 1991; 104(1): 105-12.
27. Uday G, Pravinkumar B, Manish W, Sudhir U. LHRH antagonist attenuates the effect of fluoxetine on marble-burying behavior in mice. Eur J Pharmacol. 2007; 563(1-3): 155-9.
28. Dixit PV, Sahu R, Mishra DK. Marble burying behavior test as a murine model of compulsive-like behavior. J Pharmacol Toxicol Methods. 2020; 102: 106676.
29. Robbins TW, Vaghi MM, Banca P. Obsessive-compulsive disorder: puzzles and prospects. Neuron. 2019; 102(1): 27-47.
30. Gaikwad U. Pathophysiology of obsessive-compulsive disorder: affected brain regions and challenge towards discovery of novel drug treatment. In: Obsessive-Compulsive Disorder - The Old and the New Problems. London: IntechOpen; 2014. doi:10.5772/57193.
31. Stein DJ, Ipser JC, Baldwin DS, Bandelow B. Treatment of obsessive-compulsive disorder. CNS Spectr. 2007; 12(S3): 28-35.
32. Wilson SA, Nagaraj A, Vaidyanathan L. Calocybe indicia extract modifies GABA and serotonin levels to alleviate anxiety in experimental adult zebrafish models. Res J Pharm Technol. 2021; 14(9): 4789-94.
33. Millan MJ, Dekeyne A, Papp M, Rochelle CDL, MacSweeny C, Peglion JL, et al. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther. 2001; 298(2): 581-91.
34. Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, et al. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr. 2003; 8(S1): 7-16.
35. Gyertyn I. Analysis of the marble burying response: marbles serve to measure digging rather than evoke burying. Behav Pharmacol. 1995; 6(1): 24-31.
36. What causes OCD? Understanding and treating obsessive-compulsive disorder. In: Obsessive-compulsive disorder. New York: Routledge; 2006. p. 65-85.
37. Pandian RS, Noora AT. GC-MS analysis of phytochemical compounds presents in the leaves of Citrus medica L. Res J Pharm Technol. 2019; 12(4): 1823.
38. Librowski T, Czarnecki R, Mendyk A, Jastrzebska M. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice. Pol J Pharmacol. 2000; 52(4): 317-21.